| Literature DB >> 25860604 |
Abstract
Although cancer immunotherapy can lead to durable outcomes, the percentage of patients who respond to this disruptive approach remains modest to date. Encouragingly, nanotechnology can enhance the efficacy of immunostimulatory small molecules and biologics by altering their co-localization, biodistribution, and release kinetics.Entities:
Mesh：
Substances：
Year: 2015 PMID： 25860604 DOI： 10.1016/j.cell.2015.03.037
Source DB: PubMed Journal: Cell ISSN： 0092-8674 Impact factor: 41.582